301239 Stock Overview
A specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Chengdu Bright Eye Hospital Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥49.35 |
| 52 Week High | CN¥103.50 |
| 52 Week Low | CN¥28.48 |
| Beta | 1.17 |
| 11 Month Change | 18.35% |
| 3 Month Change | 57.62% |
| 1 Year Change | -47.42% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -44.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301239 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -4.8% | -0.1% | -0.9% |
| 1Y | -47.4% | -13.3% | 5.4% |
Return vs Industry: 301239 underperformed the CN Healthcare industry which returned -13.3% over the past year.
Return vs Market: 301239 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 301239 volatility | |
|---|---|
| 301239 Average Weekly Movement | 14.1% |
| Healthcare Industry Average Movement | 8.6% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 301239's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 301239's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 4,918 | Qiang Sun | www.purui.cn |
Chengdu Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, and medical optometry for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthalmology, fundus disease, glaucoma, strabismus and pediatric ophthalmology, lacrimal duct, cornea orbital disease, eye trauma, medical optometry, and other general ophthalmology diagnosis and treatment items. The company was formerly known as Chengdu Bright Eye Hospital Co., Ltd.
Chengdu Bright Eye Hospital Group Co., Ltd. Fundamentals Summary
| 301239 fundamental statistics | |
|---|---|
| Market cap | CN¥7.35b |
| Earnings (TTM) | -CN¥33.49m |
| Revenue (TTM) | CN¥2.69b |
2.7x
P/S Ratio-219.4x
P/E RatioIs 301239 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301239 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.69b |
| Cost of Revenue | CN¥1.54b |
| Gross Profit | CN¥1.15b |
| Other Expenses | CN¥1.18b |
| Earnings | -CN¥33.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 42.83% |
| Net Profit Margin | -1.25% |
| Debt/Equity Ratio | 26.4% |
How did 301239 perform over the long term?
See historical performance and comparison